Anavex Life Sciences Corp (AVXL)

[powerwalker]

bas, if Investor were correct with the highlighted phrase below, then the read-out s/b occurring now as 48 weeks from mid-September 2022 is ~ August 20th, 2023. If the read-out is done now, that might prove to be the trial needed for AA approval, given the un-stated desire by the fda to have such a trial in progress.

Investor2014
Re: tredenwater2 post# 428126
Tuesday, August 22, 2023 10:32:34 AM

Post#
428138
of 428175
The OLE is 96 weeks, but apparently a readout is done at 48 weeks so hence completion end July 2024. The OLE then goes on for another 48 weeks, which would then keep patients on drug while hopefully AA might be granted.